herenciageneticayenfermedad: New project identifies immune checkpoint inhibition as potential treatment for angiosarcomas

jueves, 4 de octubre de 2018

New project identifies immune checkpoint inhibition as potential treatment for angiosarcomas

	October 4, 2018
	Immunology
	The latest immunology news from News Medical

Save 15% on Immuno-oncology Primary Antibodies from Abcam

Try a RabMAb rabbit monocolonal primary antibody in your lab and see for yourself how RabMAb antibodies offer you superior specificity and reproducibility.

Get Your Discount

A Single Platform to Sequence All Monoclonal Antibody Proteins

Having a single platform to sequence all monoclonal antibody proteins provides researchers with the important pieces of information they need to know at an early stage of antibody drug discovery, research and development processes.

Learn More

New type of fatty acid can slow down overreactive immune system

Sometimes, the body's otherwise intelligent immune system mistakenly attacks the body's healthy tissue by responding to infections that do not exist.

	Scientists better understand influenza virus and how it spreads The seasonal flu is caused by different subtypes of Influenza A virus and typically leads to the death of half a million people each year.

	Scientists predict how well the body will fight lung cancer by analyzing immune cell shapes Researchers at Case Western Reserve University have discovered how to quickly and accurately predict which lung cancer patients will benefit from chemotherapy by analyzing how immune cells the body sends out to fight the disease are arranged.

	Overlooked immune cells could play a key role in cancer immunotherapy, claims new study Cancer immunotherapy is a relatively new method of treating cancer and has succeeded with some refractory tumors. However, it doesn’t always work, why not?

	New project identifies immune checkpoint inhibition as potential treatment for angiosarcomas Angiosarcoma Project, a patient-partnered genomics study, identified immune checkpoint inhibition as a potential treatment option for patients with angiosarcomas of the head, face, neck, or scalp, according to data presented at the fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference.

	Immune protein 'flutters' like a butterfly in search of viruses, finds study Researchers at Rutgers Robert Wood Johnson Medical School have identified an important step in the process that allows our bodies to fight viruses.